LIP
NVO

Lighthouse Investment Partners’s Novo Nordisk NVO Stock Holding History

Lighthouse Investment Partners’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-118,000
Closed -$6.55M – 998
2025
Q3 		$6.55M Buy
+118,000
New +$6.91M 0.2% 145
2024
Q4 		– Sell
-15,500
Closed -$1.85M – 601
2024
Q3 		$1.85M Buy
+15,500
New +$2.07M 0.07% 274

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $147M AUM 25.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Lighthouse Investment Partners's NVO Position: Q1 2026 in Review

Lighthouse Investment Partners sold out of Novo Nordisk (NVO) in Q1 2026, closing a stake of 35,000 shares — an estimated $1.78M sold.

Lighthouse Investment Partners first reported a position in NVO in Q2 2024 and held it in 3 quarters. The position peaked at $3.66M in Q2 2024. 1,273 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Lighthouse Investment Partners reported no remaining Novo Nordisk position as of Q1 2026 after selling out during the quarter.
  • Lighthouse Investment Partners sold 35,000 Novo Nordisk shares in Q1 2026, an estimated $1.78M.
  • Lighthouse Investment Partners first reported a position in Novo Nordisk in Q2 2024 and held it in 3 quarters.
  • Lighthouse Investment Partners's Novo Nordisk position peaked at $3.66M in Q2 2024.
  • 1,273 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Lighthouse Investment Partners's 13F filing for Q1 2026, filed 14 May 2026.